Erik Verbeken

11.0k total citations · 1 hit paper
157 papers, 7.3k citations indexed

About

Erik Verbeken is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erik Verbeken has authored 157 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 54 papers in Surgery and 35 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erik Verbeken's work include Transplantation: Methods and Outcomes (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Cardiac Valve Diseases and Treatments (13 papers). Erik Verbeken is often cited by papers focused on Transplantation: Methods and Outcomes (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Cardiac Valve Diseases and Treatments (13 papers). Erik Verbeken collaborates with scholars based in Belgium, United States and Netherlands. Erik Verbeken's co-authors include Johan Neyts, Peter Hoet, Willem Flameng, Benoît Nemery, Bart Meyns, Georges Deneffe, Marc Decramer, Birgit Weynand, Ghislaine Gayan‐Ramirez and Jeroen Vanoirbeek and has published in prestigious journals such as Nature, Circulation and Nature Medicine.

In The Last Decade

Erik Verbeken

155 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotype molding of stromal cells in the lung tumor microenvironment

2018 1.0k citations Diether Lambrechts, Els Wauters et al. Nature Medicine profile →

Peers

Countries citing papers authored by Erik Verbeken

Since Specialization

Citations

This map shows the geographic impact of Erik Verbeken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Verbeken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Verbeken more than expected).

Fields of papers citing papers by Erik Verbeken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Verbeken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Verbeken. The network helps show where Erik Verbeken may publish in the future.

Co-authorship network of co-authors of Erik Verbeken

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Verbeken. A scholar is included among the top collaborators of Erik Verbeken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Verbeken. Erik Verbeken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiopulmonary and Immune Alterations in the Ts65Dn Mouse Model of Down Syndrome and Modulation by Epigallocatechin-3-Gallate-Enriched Green Tea Extract 2025 ·Pharmaceutics ·(unknown), (unknown), Laura Seldeslachts, Jonathan Cremer, (unknown), Anne‐Charlotte Jonckheere, (unknown), (unknown), Jens Wouters, Julia Herzen, Bartosz Leszczyński, Erik Verbeken, Jeroen Vanoirbeek, Greetje Vande Velde	0
2	Involvement of Innate Lymphoid Cells and Dendritic Cells in a Mouse Model of Chemical-induced Asthma 2021 ·Allergy Asthma and Immunology Research ·Lore Pollaris, (unknown), (unknown), Anne‐Charlotte Jonckheere, Jonathan Cremer, Erik Verbeken, Tania Maes, Fien Devos, Greetje Vande Velde, Benoît Nemery, Peter Hoet, Jeroen Vanoirbeek	3
3	Defining and predicting progression in non-IPF interstitial lung disease 2021 ·Respiratory Medicine ·(unknown), Laurens De Sadeleer, Jonas Yserbyt, Ellen De Langhe, Adriana Dubbeldam, Erik Verbeken, Geert M. Verleden, (unknown), Johny Verschakelen, Robin Vos, Birgit Weynand, Stijn E. Verleden, Wim Wuyts	4
4	A robust human norovirus replication model in zebrafish larvae 2019 ·PLoS Pathogens ·Jana Van Dycke, Annelii Ny, Nádia Conceição‐Neto, Jan Maes, Myra Hosmillo, (unknown), Ian Goodfellow, (unknown), Erik Verbeken, Jelle Matthijnssens, Peter de Witte, Johan Neyts, Joana Rocha‐Pereira	123
5	Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence 2019 ·Emerging Microbes & Infections ·Liang Sun, Aloys Tijsma, Carmen Mirabelli, Jim Baggen, (unknown), David Franco, Armando De Palma, Pieter Leyssen, Erik Verbeken, Frank J. M. van Kuppeveld, Johan Neyts, Hendrik Jan Thibaut	13
6	Phenotype molding of stromal cells in the lung tumor microenvironment breakdown → 2018 ·Nature Medicine ·Diether Lambrechts, Els Wauters, Bram Boeckx, Sara Aibar, David Nittner, Oliver T. Burton, Ayse Bassez, Herbert Decaluwé, Andreas Pircher, Kathleen Van den Eynde, Birgit Weynand, Erik Verbeken, Paul De Leyn, Adrian Liston, Johan Vansteenkiste, Peter Carmeliet, Stein Aerts, Bernard Thienpont	1037
7	Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection 2017 ·Antiviral Research ·Rana Abdelnabi, Dirk Jochmans, Erik Verbeken, Johan Neyts, Leen Delang	38
8	Morphometric Analysis of Explant Lungs in Cystic Fibrosis 2015 ·American Journal of Respiratory and Critical Care Medicine ·Mieke Boon, Stijn E. Verleden, Barbara Bosch, Elise Lammertyn, John E. McDonough, Cindy Mai, Johny Verschakelen, (unknown), Harm A.W.M. Tiddens, Marijke Proesmans, F. Vermeulen, Erik Verbeken, Joel D. Cooper, Dirk Van Raemdonck, Marc Decramer, Geert M. Verleden, James C. Hogg, Lieven Dupont, Bart Vanaudenaerde, K. De Boeck	53
9	Quantitative evaluation of CF airways using HRCT, µCT and histology 2014 ·European Respiratory Journal ·Mieke Boon, Barbara Bosch, Elise Lammertyn, Stijn E. Verleden, Pieter Goeminne, Bart Vanaudenaerde, Dirk Van Raemdonck, Erik Verbeken, Geert M. Verleden, James C. Hogg, Johny Verschakelen, Lieven Dupont, K. De Boeck	1
10	The Site and Nature of Airway Obstruction after Lung Transplantation 2014 ·American Journal of Respiratory and Critical Care Medicine ·Stijn E. Verleden, Dragoş M. Vasilescu, Stijn Willems, David Ruttens, Robin Vos, Elly Vandermeulen, Jeroen Hostens, John E. McDonough, Erik Verbeken, Johny Verschakelen, Dirk Van Raemdonck, Benoı̂t Rondelet, Christiane Knoop, Marc Decramer, Joel D. Cooper, James C. Hogg, Geert M. Verleden, Bart Vanaudenaerde	69
11	Immunological ignorance allows long-term gene expression following perinatal rAAV-mediated gene transfer to murine airways 2013 ·Human Gene Therapy ·Marianne Carlon, (unknown), James Dooley, Marina Gabriela Monteiro Carvalho Mori da Cunha, Michael Maris, (unknown), Jaan Toelen, Chris Van den Haute, Veerle Baekelandt, Jan Deprest, Erik Verbeken, Adrian Liston, Rik Gijsbers, Zeger Debyser	1
12	Diffusion-Weighted MRI Can Improve Preoperative Lung Cancer Diagnosis: The Necessity of a Meticulous ADC Curve Evaluation 2012 ·American Journal of Roentgenology ·Johan Coolen, Frederik De Keyzer, Paul De Leyn, Walter De Wever, Erik Verbeken, Kristiaan Nackaerts, Steven Dymarkowski, Johny Verschakelen	1
13	Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks 2012 ·PLoS ONE ·Stéphanie De Vleeschauwer, Wolfgang Jungraithmayr, Shana Wauters, Stijn Willems, Manuela Rinaldi, Annemie Vaneylen, Stijn E. Verleden, Anna Willems‐Widyastuti, Ken R. Bracke, Guy Brusselle, Erik Verbeken, Dirk Van Raemdonck, Geert M. Verleden, Bart Vanaudenaerde	33
14	Investigation on strain rate dependency in the biomechanical behaviour of the superior sagittal sinus – bridging vein complex 2011 ·Proceedings of the International Research Council on the Biomechanics of Injury conference ·(unknown), (unknown), Erik Verbeken, Jos Vander Sloten, Jan Goffin	2
15	Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders 2010 ·American Journal of Respiratory and Critical Care Medicine ·Bart Vanaudenaerde, Stijn E. Verleden, Robin Vos, Stéphanie I. De Vleeschauwer, Anna Willems‐Widyastuti, (unknown), Dirk Van Raemdonck, Lieven Dupont, Erik Verbeken, Isabelle Meyts	79
16	Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus 2007 ·Journal of Antimicrobial Chemotherapy ·Christopher McGuigan, Ranjith Pathirana, Marco Migliore, (unknown), (unknown), Arwyn T. Jones, (unknown), Marı́a-José Camarasa, Sonsoles Velázquez, Geoffrey Henson, Erik Verbeken, (unknown), Lieve Naesens, Robert Snoeck, Graciela Andreï, Jan Balzarini	62
17	Pulmonary effects of gastroschisis in a fetal rabbit model 2004 ·Pediatric Pulmonology ·Jean‐Marc Biard, (unknown), Kari Vanamo, (unknown), Ellen De Langhe, Erik Verbeken, Jan Deprest	2
18	Left ventricular support by Catheter-Mountedaxial flow pump reduces infarct size 2003 ·Journal of the American College of Cardiology ·Bart Meyns, (unknown), Veerle Leunens, Erik Verbeken, Willem Flameng	184
19	Reflections on the current staging system for lung cancer 2002 ·European Respiratory Review ·Johan Vansteenkiste, Jean‐Paul Sculier, Dirk Van Raemdonck, Geert M. Verleden, (unknown), Gianfranco Buccheri, (unknown), Wilfried Eberhardt, Gabriella Fontanini, Jakob R. Izbicki, Branislav Jeremić, Klaus Junker, Jacek Nikliński, Marianne Paesmans, (unknown), P Postmus, Nicolas Schönfeld, Sigrid Stroobants, Erik Verbeken, Birgit Weynand	1
20	Dobutamine stress echo may not always accurately predict segment viability in chronic global IV ischemia: an experimental study 2002 ·Journal of the American College of Cardiology ·(unknown), Frank Weidemann, Xiaoshun Liu, Yanming Huang, Alex Maes, Jan D’hooge, Bart Bijnens, Erik Verbeken, Luc Mortelmans, Frans Van de Werf, Ivan De Scheerder, George R. Sutherland	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact